These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15561957)

  • 21. Associations between structural and functional changes to the kidney in diabetic humans and mice.
    Powell DW; Kenagy DN; Zheng S; Coventry SC; Xu J; Cai L; Carlson EC; Epstein PN
    Life Sci; 2013 Aug; 93(7):257-64. PubMed ID: 23800643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.
    Nasrallah R; Robertson SJ; Karsh J; Hébert RL
    Clin Sci (Lond); 2013 Jun; 124(11):685-94. PubMed ID: 23305077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.
    Qi Z; Fujita H; Jin J; Davis LS; Wang Y; Fogo AB; Breyer MD
    Diabetes; 2005 Sep; 54(9):2628-37. PubMed ID: 16123351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy.
    Yu L; Su Y; Paueksakon P; Cheng H; Chen X; Wang H; Harris RC; Zent R; Pozzi A
    Kidney Int; 2012 Jun; 81(11):1086-97. PubMed ID: 22297672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
    Allen TJ; Waldron MJ; Casley D; Jerums G; Cooper ME
    Diabetes; 1997 Jan; 46(1):19-24. PubMed ID: 8971091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.
    Nayak BK; Shanmugasundaram K; Friedrichs WE; Cavaglierii RC; Patel M; Barnes J; Block K
    Diabetes; 2016 May; 65(5):1387-97. PubMed ID: 26908870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic glomerulopathy following unilateral nephrectomy in the dog.
    Whiteside C; Katz A; Cho C; Silverman M
    Clin Invest Med; 1990 Oct; 13(5):279-86. PubMed ID: 1703467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
    Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
    Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
    Nasrallah R; Robertson SJ; Hébert RL
    Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal tubulointerstitial fibrosis in OVE26 type 1 diabetic mice.
    Powell DW; Bertram CC; Cummins TD; Barati MT; Zheng S; Epstein PN; Klein JB
    Nephron Exp Nephrol; 2009; 111(1):e11-9. PubMed ID: 19052473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex Differences in Progression of Diabetic Cardiomyopathy in OVE26 Type 1 Diabetic Mice.
    Tang X; Jiang S; Zhang J; Zhou S; Zheng Y
    Oxid Med Cell Longev; 2020; 2020():6961348. PubMed ID: 32509150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
    Trachtman H; Futterweit S; Pine E; Mann J; Valderrama E
    Pediatr Nephrol; 2002 Jan; 17(1):20-9. PubMed ID: 11793130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of varied protein intake on the nephropathy of the diabetic mouse (C57BL/s J db/db).
    Brouhard BH; Rajaraman S; LaGrone LF
    Int J Pediatr Nephrol; 1987; 8(2):59-68. PubMed ID: 3308729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular structure and function in diabetic nephropathy. Early to advanced stages.
    Osterby R; Parving HH; Hommel E; Jørgensen HE; Løkkegaard H
    Diabetes; 1990 Sep; 39(9):1057-63. PubMed ID: 2384188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
    Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
    Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic glomerulopathy in young IDDM patients. Preventive and diagnostic aspects.
    Rudberg S; Osterby R
    Horm Res; 1998; 50 Suppl 1():17-22. PubMed ID: 9676992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of incipient nephropathy in type 2 diabetes mellitus.
    Lemley KV; Abdullah I; Myers BD; Meyer TW; Blouch K; Smith WE; Bennett PH; Nelson RG
    Kidney Int; 2000 Sep; 58(3):1228-37. PubMed ID: 10972685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.